榴莲视频

Ingrid Hein

Ingrid Hein

Authors >

Ingrid Hein

Ingrid Hein has been a medical reporter for more than a decade. Before joining 榴莲视频, she covered medical conferences for WebMD / Medscape Medical News. Previous to writing about health, Ingrid put her BA in journalism from Concordia University to work as a technology reporter and columnist. She appeared as a panelist on CBC radio and wrote weekly columns for Toronto and Montreal newspapers. Ingrid lives just outside the Montreal area, in Canada. She keeps chickens, makes pottery, and enjoys staying healthy doing sports that can be done in the woods or without wearing shoes.

Connect:

email image

Latest from Ingrid Hein

A computer rendering of mpox lesions.

CDC Offers Tentative Guidance for Severe Mpox Treatment

While awaiting trial evidence, CDC summarizes the clinical considerations

FDA VRBPAC RSVPreF3 vaccine (AREXVY) over a computer rendering of a cutaway RSV virus.

Second RSV Vaccine for Older Adults Gets Thumbs Up From FDA Advisors

VRBPAC unanimously endorses efficacy of GSK's protein fusion vaccine, not quite as sold on safety

FDA VRBPAC RSV prefusion F protein vaccine (ABRYSVO) over a computer rendered cutaway of the RSV virus.

FDA Panel Backs Pfizer's RSV Vaccine for Older Adults

But panelists raise multiple concerns over phase III trial data

A computer rendered cutaway view of the respiratory syncytial virus

FDA Flags Potential Guillain-Barre Risk With RSV Vaccine Candidates

Both vaccines demonstrated high efficacy against symptomatic illness in large phase III trials

CROI over a photo of the Seattle Convention Center Summit in Seattle, Washington.

What Next After Early End of MOSAICO HIV Vaccine Trial?

Main focus now will be approaches using broadly neutralizing HIV-1 antibodies, researchers say

CROI over a photo of the Seattle Convention Center Summit in Seattle, Washington.

Severe Mpox in Advanced HIV Patients Tied to Complications, Death

Researchers argue that severe mpox is AIDS-defining; critics say that's stigmatizing

CROI over a photo of the Seattle Convention Center Summit in Seattle, Washington.

Investigational Oral Antiviral Shows Promise in COVID Outpatients

Exploratory analyses also point to possible reduction in long COVID symptoms

CROI over a photo of the Seattle Convention Center Summit in Seattle, Washington.

COVID Rebound Not Exclusive to Those on Paxlovid

However, these rebound cases were rare and lasted only about 1 day

CROI over a photo of the Seattle Convention Center Summit in Seattle, Washington.

TB Treatment Strategy Has Potential to Drastically Slash Therapy Duration

8-week regimen, with more for persistent cases, yields similar outcomes to 6-month standard

A computer rendering of the Marburg virus

What Do We Know About Marburg Virus Disease?

WHO announced that Equatorial Guinea confirmed its first outbreak of the rare disease

4

鈥�